AJ91 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetDocCheck’s very low leverage (debt ≈ 0.10x equity in 2025) and sizeable equity relative to assets provide durable financial flexibility. This conservatism reduces refinancing and solvency risk, supports investment or dividend capacity, and cushions the business during cyclical revenue swings.
Specialized, Verified Healthcare Professional NetworkThe company’s core asset— a verified professional healthcare community and specialized B2B offerings—creates a durable competitive position. Focused industry relevance and trusted access to HCPs support recurring revenue from marketing, content and platform services, making client relationships stickier over time.
Healthy Margins And Profitability ResilienceDespite revenue volatility, DocCheck sustains high‑teens EBITDA and about 10% net margins, demonstrating structural cost discipline and pricing power. Persistent margins support cash generation, dividend capacity and reinvestment potential even if topline growth moderates in the medium term.
Bears Say
Volatile Revenue And 2025 DeclineThe sustained revenue volatility and the explicit decline in 2025 weaken predictability of top‑line performance. For a B2B services provider, uneven sales hinder capacity planning and limit the ability to steadily scale margins or fund multi‑year growth initiatives without relying on one‑off measures.
Weaker Free Cash Flow And Cash ConversionA sharp drop in free cash flow and operating cash covering only ~50%+ of accounting profit indicate weakening cash quality. This reduces available internal funds for capex, acquisitions or dividends and increases sensitivity to working‑capital swings, constraining strategic flexibility.
Uneven Operating Performance And Normalized GrowthOperating results have normalized below the 2020–2021 peaks and remain inconsistent. This suggests a lower structural growth trajectory and intermittent operating leverage benefits, making sustained expansion and improvements in return metrics less certain over the next several quarters.
DocCheck AG News
AJ91 FAQ
What was DocCheck AG’s price range in the past 12 months?
Currently, no data Available
What is DocCheck AG’s market cap?
DocCheck AG’s market cap is CHF54.81M.
When is DocCheck AG’s upcoming earnings report date?
DocCheck AG’s upcoming earnings report date is Aug 04, 2026 which is in 9 days.
How were DocCheck AG’s earnings last quarter?
DocCheck AG released its earnings results on Feb 06, 2026. The company reported CHF0.523 earnings per share for the quarter, beating the consensus estimate of N/A by CHF0.523.
Is DocCheck AG overvalued?
According to Wall Street analysts DocCheck AG’s price is currently Undervalued.
Does DocCheck AG pay dividends?
DocCheck AG does not currently pay dividends.
What is DocCheck AG’s EPS estimate?
DocCheck AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DocCheck AG have?
Currently, no data Available
What happened to DocCheck AG’s price movement after its last earnings report?
DocCheck AG reported an EPS of CHF0.523 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of DocCheck AG?
Currently, no hedge funds are holding shares in CH:AJ91
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocCheck AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.06%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-8.52%
Trailing 12-Months
Company Description
DocCheck AG
DocCheck AG offers community, agency, and e-commerce services for the healthcare sector in Europe. The company develops and implements communication strategies for media on healthcare and business-to-business sectors; sells medical supplies and medical technology primarily via mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.
CompuGroup Medical
―
MeVis Medical Solutions
―
Medios AG
―
MediNavi AG
―
Novetum AG
―